Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eloisa A V Ferro"'
Autor:
Adele A Rodrigues, Jasson S S Saosa, Grace K da Silva, Flávia A Martins, Aline A da Silva, Cecílio P da Silva Souza Neto, Catarina V Horta, Dario S Zamboni, João S da Silva, Eloisa A V Ferro, Claudio V da Silva
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 6, Iss 4, p e1598 (2012)
BACKGROUND: T. cruzi strains have been divided into six discrete typing units (DTUs) according to their genetic background. These groups are designated T. cruzi I to VI. In this context, amastigotes from G strain (T. cruzi I) are highly infective in
Externí odkaz:
https://doaj.org/article/af317c4efc664c8ca95a451c8123aeb0
Autor:
Mariana B. Santiago, Vinicius Cristian O. dos Santos, Samuel C. Teixeira, Nagela B. S. Silva, Pollyanna F. de Oliveira, Saulo D. Ozelin, Ricardo A. Furtado, Denise C. Tavares, Sergio Ricardo Ambrósio, Rodrigo Cassio S. Veneziani, Eloisa Amália V. Ferro, Jairo K. Bastos, Carlos Henrique G. Martins
Publikováno v:
Pharmaceuticals, Vol 16, Iss 10, p 1357 (2023)
This study aimed at evaluating the potential of Copaifera lucens, specifically its oleoresin (CLO), extract (CECL), and the compound ent-polyalthic acid (PA), in combating caries and toxoplasmosis, while also assessing its toxicity. The study involve
Externí odkaz:
https://doaj.org/article/e0cf14e1a7f9470c85728b3b220e2270
Autor:
Angelica O. Gomes, Bellisa F. Barbosa, Priscila S. Franco, Mayara Ribeiro, Rafaela J. Silva, Paula S. G. Gois, Karine C. Almeida, Mariana B. Angeloni, Andressa S. Castro, Pâmela M. Guirelli, João V. Cândido, Javier E. L. Chica, Neide M. Silva, Tiago W. P. Mineo, José R. Mineo, Eloisa A. V. Ferro
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Migration inhibitory factor (MIF) is a pro-inflammatory cytokine that plays important roles in physiology, pathology, immunology and parasitology, including the control of infection by protozoa parasites such as Toxoplasma gondii. As the MIF function
Externí odkaz:
https://doaj.org/article/da0c446364e3411cb01151cef8779651
Autor:
Rafaela J, da Silva, Angelica O, Gomes, Priscila S, Franco, Ariane S, Pereira, Iliana C B, Milian, Mayara, Ribeiro, Paolo, Fiorenzani, Maria C, Dos Santos, José R, Mineo, Neide M, da Silva, Eloisa A V, Ferro, Bellisa, de Freitas Barbosa
Publikováno v:
Frontiers in Cellular and Infection Microbiology
Classical treatment for congenital toxoplasmosis is based on combination of sulfadiazine and pyrimethamine plus folinic acid. Due to teratogenic effects and bone marrow suppression caused by pyrimethamine, the establishment of new therapeutic strateg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dbfdec507dd6ecc442c1907c5b20b0b8
https://pubmed.ncbi.nlm.nih.gov/28798905
https://pubmed.ncbi.nlm.nih.gov/28798905